Status:
COMPLETED
Study to Assess the Effect of Ticagrelor on Coronary Blood Flow in Healthy Male Subjects.
Lead Sponsor:
AstraZeneca
Conditions:
Blood Flow Speed
Coronary Flow Velocity
Eligibility:
MALE
18-40 years
Phase:
PHASE1
Brief Summary
The purpose of this study is to determine if Ticagrelor increases the Adenosin induced coronary blood flow velocity.
Eligibility Criteria
Inclusion
- Suitable for ECG recording of CBFV and have no adverse reaction to adenosine challenge
- Have a body mass index between 18 and 30 kg/m2
Exclusion
- History of clinically significant disease or disorder.
- Abnormal vital signs
Key Trial Info
Start Date :
December 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2011
Estimated Enrollment :
39 Patients enrolled
Trial Details
Trial ID
NCT01226602
Start Date
December 1 2010
End Date
April 1 2011
Last Update
February 13 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Research Site
Uppsala, Sweden